資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

頁面路徑選單

Global Ocular Implants Market 2018-2022

  • LinkedIn
  • facebook
  • Twitter
出 版 商:Technavio
出版日期:2018/07/16
頁  數:126頁
文件格式:PDF
價  格:
USD 2,500 (Single-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
線上訂購或諮詢
About Ocular Implants
Ocular implants are medical devices designed to replace a damaged or missing visual organ to restore vision or to improve visual appearance. Ocular implants such as ocular prostheses are artificial eyes used by people to improve facial lineaments damages due to an eye disease or trauma.

Technavio’s analysts forecast the global ocular implants market to grow at a CAGR of 12.52% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global ocular implants market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of IOLs, corneal implants, glaucoma implants, and ocular prostheses.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA

Technavio's report, Global Ocular Implants Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
‧ Carl Zeiss Meditec
‧ Johnson & Johnson
‧ MORCHER
‧ NIDEK
‧ Novartis
‧ Valeant Pharmaceuticals

Market driver
‧ Increasing access to ocular implants in emerging markets
‧ For a full, detailed list, view our report

Market challenge
‧ Limited reimbursements for ocular implants
‧ For a full, detailed list, view our report

Market trend
‧ Increasing medical tourism for cataract surgery
‧ For a full, detailed list, view our report

Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
‧ Segmentation by product
‧ Comparison by product
‧ IOLs
‧ Glaucoma implants
‧ Corneal implants
‧ Ocular prostheses
‧ Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Americas – Market size and forecast 2017-2022
‧ EMEA – Market size and forecast 2017-2022
‧ APAC – Market size and forecast 2017-2022
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ Custom-made ocular prostheses
‧ Increasing preference for ASCs over hospitals for ophthalmology procedures
‧ Increasing medical tourism for cataract surgery
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Carl Zeiss Meditec
‧ Johnson & Johnson
‧ MORCHER
‧ NIDEK
‧ Novartis
‧ Valeant Pharmaceuticals
PART 15: APPENDIX
‧ List of abbreviations
Exhibit 01: Global ophthalmology devices market
Exhibit 02: Global ophthalmology devices market – Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global ocular implants market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global ocular implants market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global ocular implants market by product – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global IOLs market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global IOLs market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global glaucoma implants market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global glaucoma implants market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Global corneal implants market – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global corneal implants market – Year-over-year growth 2018-2022 (%)
Exhibit 26: Global ocular prostheses market – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Global ocular prostheses market – Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Global ocular implants market share by geography 2017-2022 (%)
Exhibit 31: Global ocular implants market – Regional comparison
Exhibit 32: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 34: Top 3 countries in Americas
Exhibit 35: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 37: Top 3 countries in EMEA
Exhibit 38: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 39: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 40: Top 3 countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Carl Zeiss Meditec – Overview
Exhibit 48: Carl Zeiss Meditec – Business segments
Exhibit 49: Carl Zeiss Meditec – Organizational developments
Exhibit 50: Carl Zeiss Meditec – Geographic focus
Exhibit 51: Carl Zeiss Meditec – Segment focus
Exhibit 52: Carl Zeiss Meditec – Key offerings
Exhibit 53: Carl Zeiss Meditec – Key customers
Exhibit 54: Johnson & Johnson – Overview
Exhibit 55: Johnson & Johnson – Business segments
Exhibit 56: Johnson & Johnson – Organizational developments
Exhibit 57: Johnson & Johnson – Geographic focus
Exhibit 58: Johnson & Johnson – Segment focus
Exhibit 59: Johnson & Johnson – Key offerings
Exhibit 60: Johnson & Johnson – Key customers
Exhibit 61: MORCHER – Overview
Exhibit 62: MORCHER – Product segments
Exhibit 63: MORCHER – Organizational developments
Exhibit 64: MORCHER – Geographic focus
Exhibit 65: MORCHER – Product segment focus
Exhibit 66: MORCHER – Key offerings
Exhibit 67: MORCHER – Key customers
Exhibit 68: NIDEK – Overview
Exhibit 69: NIDEK – Product segments
Exhibit 70: NIDEK – Organizational developments
Exhibit 71: NIDEK – Geographic focus
Exhibit 72: NIDEK – Product segment focus
Exhibit 73: NIDEK – Key offerings
Exhibit 74: NIDEK – Key customers
Exhibit 75: Novartis – Overview
Exhibit 76: Novartis – Business segments
Exhibit 77: Novartis – Organizational developments
Exhibit 78: Novartis – Geographic focus
Exhibit 79: Novartis – Segment focus
Exhibit 80: Novartis – Key offerings
Exhibit 81: Novartis – Key customers
Exhibit 82: Valeant Pharmaceuticals – Overview
Exhibit 83: Valeant Pharmaceuticals – Business segments
Exhibit 84: Valeant Pharmaceuticals – Organizational developments
Exhibit 85: Valeant Pharmaceuticals – Geographic focus
Exhibit 86: Valeant Pharmaceuticals – Segment focus
Exhibit 87: Valeant – Key offerings
Exhibit 88: Valeant Pharmaceuticals – Key customers
回上頁